# Assessment vNext+256 Edges

Status: post-closeout edge assessment for `PB-TRIAL-0-C`.

Authority layer: closeout evidence on `main`.

## Assessment-State Marker (Machine-Checkable)

```json
{
  "schema": "assessment_artifact_state@1",
  "artifact": "docs/ASSESSMENT_vNEXT_PLUS256_EDGES.md",
  "phase": "post_closeout_assessment",
  "authoritative": true,
  "required_in_decision": true
}
```

## Edge Review

### Edge 1: C Rows Could Bypass Released A/B Trial Law

- Closeout state:
  contained.
- Evidence:
  `validate_pb_trial_0c_closeout_bundle` consumes released A docket, runbook,
  readiness, and guardrail rows plus released B dispatch, capture, snapshot,
  and lifecycle projection rows.

### Edge 2: C Could Accept A Stale B Execution Chain

- Closeout state:
  contained after review fix.
- Evidence:
  C closeout validation now delegates to `validate_pb_trial_0b_execution_bundle`
  before C-specific checks. A regression rejects stale dispatch/runbook
  lineage, preserving the B chain for closeout.

### Edge 3: Outcome Audit Could Claim Official Benchmark Truth

- Closeout state:
  contained.
- Evidence:
  outcome audits carry explicit no-hidden-test-equivalence, not-benchmark-truth,
  no-model-ranking, and no-official-submission postures. Invalid authority
  postures fail closed.

### Edge 4: Local Acceptance Could Ignore Missing Evidence

- Closeout state:
  contained.
- Evidence:
  `trial_locally_accepted` requires no blockers, passed runbook and sandbox
  satisfaction rows, snapshot-inside-write-scope evidence, execution-capture
  evidence, and lifecycle-projection validation evidence.

### Edge 5: Observation Summary Could Become A Model Ranking

- Closeout state:
  contained.
- Evidence:
  observation summaries are single-trial-only and reject comparative language
  across models, attempts, retries, benchmark rows, or leaderboard posture.

### Edge 6: Observation Summary Could Overstate Scope

- Closeout state:
  contained.
- Evidence:
  summaries preserve the observed input packet hash, candidate snapshot hash,
  and outcome posture for one local trial only. They cannot carry benchmark
  truth, model ranking, or comparison authority.

### Edge 7: Remand Decision Could Cite Forbidden Sources

- Closeout state:
  contained.
- Evidence:
  remand source kinds are local-only. Hidden-test failure, official evaluator
  feedback, original-source facts, decompilation facts, internet lookup facts,
  and external-repo facts are rejected by schema/validator posture.

### Edge 8: Remand Decision Could Become Retry Authority

- Closeout state:
  contained.
- Evidence:
  remand rows carry pressure only and require
  `retry_authority_posture = no_retry_authority_granted_by_pb_trial_0c`.

### Edge 9: Family Closeout Could Select The Next Family

- Closeout state:
  contained.
- Evidence:
  family closeout alignment closes exactly `PB-TRIAL-0-A`, `PB-TRIAL-0-B`, and
  `PB-TRIAL-0-C` and requires
  `future_family_selection_posture = no_future_family_selected_by_pb_trial_0c`.

### Edge 10: C Could Emit Execution Or Candidate Mutation Artifacts

- Closeout state:
  contained.
- Evidence:
  C emits only outcome audit, observation summary, remand decision, and family
  closeout alignment shapes. Dispatch, execution capture, candidate snapshot,
  candidate materialization, and command execution remain outside C.

## Residual Edges

- `PB-TRIAL-0` closes one local cleanroom trial lifecycle only.
- Retry dispatch authority and multi-attempt comparison remain unselected.
- Official ProgramBench participation, hidden evaluator integration,
  benchmark scoring, model ranking, official submissions, broader benchmark
  result governance, product, graph, release, and recursive-policy work remain
  unselected.
- The next ProgramBench practical arc requires a fresh selector/lock and cannot
  be inferred from this closeout.

## Current Judgment

- `PB-TRIAL-0-C` is closed on `main` as a bounded local cleanroom trial outcome
  audit, observation summary, remand-decision, and family-closeout slice.
- The full `PB-TRIAL-0` family is ready to close as one local trial lifecycle
  only.
